Back to Search
Start Over
ADVANCE system testing: estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data
- Source :
- Dodd, C, de Ridder, M, Weibel, D, Mahaux, O, Haguinet, F, de Smedt, T, de Lusignan, S, McGee, C, Duarte-Salles, T, Emborg, H D, Huerta-Alvarez, C, Martín-Merino, E, Picelli, G, Berencsi, K, Danieli, G & Sturkenboom, M 2020, ' ADVANCE system testing : Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data ', Vaccine, vol. 38, no. 2, pp. B47-B55 . https://doi.org/10.1016/j.vaccine.2020.03.050, Vaccine, 38, B47-B55. Elsevier
- Publication Year :
- 2020
- Publisher :
- Elsevier, 2020.
-
Abstract
- The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public–private collaboration aiming to develop and test a system for rapid vaccine benefit-risk monitoring using existing European healthcare databases. Incidence rate (IR) estimates of vaccination-associated adverse events that are needed to model vaccination risks can be calculated from existing healthcare databases when vaccination (exposure) data are available. We assessed different methods to derive IRs in risk periods following vaccination when exposure data are missing in one database, using estimated IRs and IRRs from other databases for febrile seizures, fever and persistent crying. IRs were estimated for children aged 0–5 years in outcome-specific risk and non-risk periods following the first dose of acellular pertussis (aP) vaccination in four primary care databases and one hospital database. We compared derived and observed IRs in each database using three methods: 1) multiplication of non-risk period IR for database i by IR ratio (IRR) obtained from meta-analysis of IRRs estimated using the self-controlled case-series method, from databases other than i; 2) same method as 1, but multiplying with background IR; and 3) meta-analyses of observed IRs from databases other than i. IRs for febrile seizures were lower in primary care databases than the hospital database. The derived IR for febrile seizures using data from primary care databases was lower than that observed in the hospital database, and using data from the hospital database gave a higher derived IR than that observed in the primary care database. For fever and persistent crying the opposite was observed. We demonstrated that missing IRs for a post-vaccination period can be derived but that the type of database and the method of event data capture can have an impact on potential bias. We recommend IRs are derived using data from similar database types (hospital or primary care) with caution as even this can give heterogeneous results.
- Subjects :
- Databases, Factual
Whooping Cough
030231 tropical medicine
Database heterogeneity
Primary care
computer.software_genre
03 medical and health sciences
0302 clinical medicine
SDG 3 - Good Health and Well-being
Health care
Medicine
Electronic Health Records
Humans
Pertussis vaccination
030212 general & internal medicine
Adverse effect
Child
Incidence rate derivation
General Veterinary
General Immunology and Microbiology
Database
business.industry
Incidence (epidemiology)
Incidence
Vaccination
Public Health, Environmental and Occupational Health
Infant, Newborn
Infant
Missing exposure data
Adverse events following vaccination
Europe
Infectious Diseases
Child, Preschool
Molecular Medicine
business
computer
Delivery of Health Care
Exposure data
Acellular pertussis
Subjects
Details
- Language :
- English
- ISSN :
- 0264410X
- Database :
- OpenAIRE
- Journal :
- Dodd, C, de Ridder, M, Weibel, D, Mahaux, O, Haguinet, F, de Smedt, T, de Lusignan, S, McGee, C, Duarte-Salles, T, Emborg, H D, Huerta-Alvarez, C, Martín-Merino, E, Picelli, G, Berencsi, K, Danieli, G & Sturkenboom, M 2020, ' ADVANCE system testing : Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data ', Vaccine, vol. 38, no. 2, pp. B47-B55 . https://doi.org/10.1016/j.vaccine.2020.03.050, Vaccine, 38, B47-B55. Elsevier
- Accession number :
- edsair.doi.dedup.....e6aae30ffa7b532607ef5cf9ce5045f5
- Full Text :
- https://doi.org/10.1016/j.vaccine.2020.03.050